More precise data means more power to cure. Fueled by our increased understanding of the very building blocks of human life, Weill Cornell Medicine is leading a revolution in modern medicine.
By bringing together diverse streams of information spanning genomics, social determinants of health, environmental exposures, electronic health records and wearable device data, our scientists gain greater insights into each patient’s unique genetic ecosystem, allowing us to create a more complete picture of a patient’s health. Weill Cornell Medicine’s diverse patient base puts us in a unique position to create individual treatment strategies that are more effective and curative.
Close collaborations among the Meyer Cancer Center, the Englander Institute for Precision Medicine, and researchers in Molecular and Genomic Pathology have established Weill Cornell Medicine at the forefront of precision medicine in the diagnosis and treatment of cancer.
As advancements in precision health continue, their results will inform our work across the entire institution—bolstering innovations and programs that have the potential to revolutionize research and collaborative patient care. Our goal is to make these strategies a routine part of health care—giving us the ability to dramatically improve the well-being of patients around the world.
